PubRank

S Battista

Author PubWeight™ 30.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 High level expression of the HMGI (Y) gene during embryonic development. Oncogene 1996 2.13
2 Role of the high mobility group A proteins in human lipomas. Carcinogenesis 2001 2.08
3 Abnormal left ventricular intracavitary flow acceleration in patients undergoing aortic valve replacement for aortic stenosis. A marker for high postoperative morbidity and mortality. Circulation 1992 1.72
4 The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene 1995 1.61
5 Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc Natl Acad Sci U S A 2001 1.60
6 Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression. Oncogene 1997 1.57
7 Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J 1997 1.51
8 Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res 1996 1.37
9 Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation. Mol Cell Biol 2001 1.26
10 Left ventricular hypertrophy and mortality after aortic valve replacement for aortic stenosis. A high risk subgroup identified by preoperative relative wall thickness. J Am Coll Cardiol 1993 1.17
11 A novel member of the BTB/POZ family, PATZ, associates with the RNF4 RING finger protein and acts as a transcriptional repressor. J Biol Chem 2000 1.16
12 FRA-1 expression in hyperplastic and neoplastic thyroid diseases. Clin Cancer Res 2000 1.10
13 Effects of fibronectin and laminin on structural, mechanical and transport properties of 3D collageneous network. J Mater Sci Mater Med 2007 1.02
14 The performance of poly-epsilon-caprolactone scaffolds in a rabbit femur model with and without autologous stromal cells and BMP4. Biomaterials 2007 0.95
15 Overexpression of proteins HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells. Cancer Res 2001 0.89
16 Evaluation of hepatic function in liver cirrhosis: clinical utility of galactose elimination capacity, hepatic clearance of D-sorbitol, and laboratory investigations. Dig Dis Sci 1999 0.83
17 Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease. Am J Transplant 2008 0.82
18 Influence of bone tissue density and elasticity on ultrasound propagation: an in vitro study. J Bone Miner Res 2000 0.82
19 Validation of ICTERUS, a knowledge-based expert system for Jaundice diagnosis. Methods Inf Med 2000 0.81
20 Reproducibility of the WHO classification of thymomas: practical implications. Lung Cancer 2012 0.80
21 Bacterial and mammalian cell mutagenicity of four optically active bay-region 10,11-diol-8,9-epoxides of the nitrogen heterocycle dibenz[a,h]acridine. Carcinogenesis 1993 0.79
22 Sorbitol removal by the metastatic liver: a predictor of systemic toxicity of intra-arterial chemotherapy in patients with liver metastases. J Hepatol 1999 0.79
23 Determination of functional portal-systemic shunting in patients submitted to hepatic angiography. Liver 1996 0.78
24 Hepatic arterial infusion chemotherapy for unresectable confined liver metastases: prediction of systemic toxicity with the application of a scintigraphic and pharmacokinetic approach. Cancer Chemother Pharmacol 1999 0.78
25 Arterial-venous shunting in liver cirrhosis. Dig Dis Sci 1998 0.78
26 Short-term effects of transjugular intrahepatic portosystemic shunt (TIPS) on functional liver plasma flow in patients with advanced cirrhosis. Liver 1998 0.77
27 Effect of perioperative infusion of antioxidants on neutrophil activation during liver transplantation in humans. Transplant Proc 2002 0.77
28 A systems approach in hepatology. Forum (Genova) 1999 0.75
29 [Reduced glutathione and anaerobic threshold]. Clin Ter 1996 0.75
30 Prediction by mathematical simulation of different pathophysiological effects on D-sorbitol bioavailability. Comput Biol Med 1998 0.75
31 [Use of an automatic blood glucose measurement system for the assessment of insulin resistance during the oral glucose tolerance test]. Minerva Endocrinol 1991 0.75
32 Definition consensus workshop for the ultrasonic assessment of bone 15th December 1995 (Paris). Clin Rheumatol 1997 0.75
33 Laser facilitated angioplasty and thrombolysis in acute myocardial infarction complicated by prolonged or recurrent chest pain. Cathet Cardiovasc Diagn 1993 0.75
34 Computer-aided diagnosis in jaundice: comparison of knowledge-based and probabilistic approaches. Methods Inf Med 1996 0.75
35 Scoring procedures in clinical hepatology. Forum (Genova) 1999 0.75
36 Ultrasound transmission speed and ultrasound bone profile score (UBPS) of the phalanges in normal women and women with osteoporosis. Horm Metab Res 1998 0.75
37 Biomimetic structures for implants and tissue engineering scaffolds. Med J Malaysia 2004 0.75
38 Quantitative ultrasound of the proximal phalanges: reproducibility in erosive and nodal osteoarthritis of the hands. Int J Tissue React 1999 0.75